Galmed Pharmaceuticals GLMD
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.75 | 3.97 | -3,042 | -5 | ||
| 2025Q3 | 1.38 | -0.33 | -2,095 | -2 | ||
| 2025Q2 | 1.84 | -0.63 | -2,109 | -2 | ||
| 2025Q1 | 1.44 | -0.62 | -1,264 | -1 | ||
| 2024Q4 | 3.19 | 36.16 | -1,644 | -3 | ||
| 2024Q3 | 6.86 | -2.31 | -2,011 | -2 | ||
| 2024Q2 | 3.3 | -1.65 | -1,222 | -1 | ||
| 2024Q1 | 4.16 | -2.1 | -1,401 | -1 | ||
| 2023Q4 | 5.46 | -2,151 | -2 | |||
| 2023Q3 | 7.44 | -41.16 | -1,468 | -1 | ||
| 2023Q2 | 35.88 | -11.4 | -1,871 | -2 | ||
| 2023Q1 | 76.77 | -12.96 | -2,002 | -2 | ||
| 2022Q4 | 90 | -1.5 | -2,449 | -3 | ||
| 2022Q3 | 56 | -38.29 | -5,380 | -5 | ||
| 2022Q2 | 117 | -27 | -3,730 | -4 | ||
| 2022Q1 | 286.2 | -44.05 | -6,092 | -6 | ||
| 2021Q4 | 327.6 | -7,492 | -7 | |||
| 2021Q3 | 502.2 | -55.8 | -7,845 | -8 | ||
| 2021Q2 | 547.2 | -59.4 | -8,412 | -8 | ||
| 2021Q1 | 617.4 | -68.4 | -9,132 | -9 |